Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high94.900 17/11/16
52 week low9.525 19/07/17
52 week change -63.500 (-67.55%)
4 week volume1,633,807 22/10/17

Media for (AVO)

Presenter: AVO Team
22/10/2017
Presenter: Nicolas Serandour
04/09/2017

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

AVO - Progress at Harley Street, timelapse

Advanced Oncotherapy operating losses widen

Advanced Oncotherapy's operating losses rose to 7.3m in the six months to the end of June - up from 5.9m last time. Revenu...

Half-year Report

RNS Number: 1735S Advanced Oncotherapy PLC 29 September 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Half-year Report Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces its unaudited results for the six months ended 30 June 2017 and po...

Advanced Oncotherapy - Technological update

Technological update

RNS Number: 6608P Advanced Oncotherapy PLC 04 September 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Technological update Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it remains on schedule with the development of the first L...

Advance Oncotherapy - Interview with Gabriel Urwitz

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 100,000 shares in the company on the 31st July 2017 at a price of 17.75p. T...

Director Dealing

RNS Number: 6440M Advanced Oncotherapy PLC 01 August 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that yesterday Dr Enrico Vanni, Non-Executive Director of the Com...

Fundamental DataMore

EPS-17.01
Dividend yield0 %

Latest discussion posts More

  • Re: Price rise

    Wow that's more than enough to cover the next few years and take them past live for Harley Street. I suppose it depends on how much they have to give away in equity, their ...
    6-Oct-2017
    fish lips
  • Re: Price rise

    Rumour of new funding - some say #100m new funding.
    6-Oct-2017
    Go Dink
  • Re: Price rise

    Had a look on their website and the was ...
    5-Oct-2017
    fish lips

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..
LLOYDS GRP.20%
SIRIUS MINERALS16%
TESCO13%
ROYAL BANK SCOT12%
TAYLOR WIMPEY11%

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account